Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...

Unemployed people will be given weight-loss jabs under Government plans to get them back to work. Wes Streeting, the Health ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

Wegovy has quickly gained popularity as a highly effective weight loss medication, but it's not always accessible due to the need for a prescription and its high cost. As a result, many people are ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads.